Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
37.77
+0.19 (0.51%)
At close: Jun 8, 2026, 4:00 PM EDT
40.98
+3.21 (8.49%)
After-hours: Jun 8, 2026, 7:57 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.68 billion as of June 8, 2026. Its market cap has increased by 89.27% in one year.
Market Cap
2.68B
Enterprise Value
1.24B
1-Year Change
89.27%
Ranking
Category
Stock Price
$37.77
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.68B, an increase of 389.11%. That is a compound annual growth rate of 60.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 2.68B | -44.18% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.93B |
| Tango Therapeutics | 2.92B |
| Arcus Biosciences | 2.92B |
| Dyne Therapeutics | 2.82B |
| Arcutis Biotherapeutics | 2.66B |
| Definium Therapeutics | 2.57B |
| Disc Medicine | 2.56B |
| Tarsus Pharmaceuticals | 2.55B |